NEW YORK, Oct. 26, 2023 /PRNewswire/ -- Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results of the Patient Advocates for Lupus Studies (PALS) pilot study were recently published in The Open Rheumatology Journal, the official open-access journal of the American College of Rheumatology. The PALS (Patient Advocates for Lupus Studies) Program was created to increase knowledge, positive attitudes toward, and intentions